Sales and Marketing

Showing 15 posts of 11527 posts found.

Immunocore chief executive cements role at Adaptimmune

March 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, immunocore, noble

Biotech firm Adaptimmune has confirmed the full-time appointment of James Noble as its chief executive. Noble has been chief executive …

Adaptimmune wins fund payout

March 26, 2014 Research and Development, Sales and Marketing Adaptimmune, Cancer, T cell, biomedical, noble, sme

Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …

UK government launches ‘Sign up to Safety’ initiative

March 26, 2014 Sales and Marketing Francis, Hunt, Mid Staffs, NHS, safety, sign up

A new ambition to reduce avoidable harm in the NHS by half over the next three years, cut costs and …

Pfizer’s Xalkori impresses in new setting

March 26, 2014 Research and Development, Sales and Marketing NHS, NICE, NSCLC, Pfizer, Xalkori, lung cancer

Pfizer’s lung cancer treatment Xalkori has proven better at treating patients in a first-line setting when compared to chemotherapy. This …

J&J appoints chief design officer

March 26, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ernesto Quinteros, J&J, JJ, belkin, design

Johnson & Johnson has reached outside of its industry and into the design and technology realm with its latest appointment.  …

FDA unconvinced on Novartis heart drug

March 26, 2014 Research and Development, Sales and Marketing FDA, Novartis, ahf, heart, serelaxin

The prospects of Novartis’ latest heart drug being approved in the US anytime soon appear to have been scuppered by …

EFPIA hires director of European affairs

March 25, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, kuiper

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Elizabeth Kuiper to be the director of its European …

Parexel expands international operation

March 25, 2014 Manufacturing and Production, Sales and Marketing Parexel, Singapore, manufacturing

Biopharma services provider Parexel International Corporation is beefing up its global capacity and adding more secondary packaging and labelling services …

Xolair gets FDA approval for skin condition

March 24, 2014 Research and Development, Sales and Marketing FDA, Novartis, Roche, Sanofi, Xolair, chronic hives, csu

 An asthma drug developed by Roche subsidiary Genentech and Novartis has been granted an additional indication to treat chronic hives …

CHMP recommends Jardiance

March 24, 2014 Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly

Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …

Endocyte lung cancer drug shows promise

March 24, 2014 Research and Development, Sales and Marketing Endocyte, MSD, NSCLC, lung cancer, vintafolide

Endocyte and partner MSD have released positive mid-stage trial results for their investigational lung cancer drug vintafolide. The treatment met …

NICE says ‘no’ to Xofigo

March 24, 2014 Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo

NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …
The Gateway to Local Adoption Series

Latest content